Inspire Medical Systems, Inc. $INSP Shares Purchased by CW Advisors LLC

CW Advisors LLC boosted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 45.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,960 shares of the company’s stock after buying an additional 15,576 shares during the quarter. CW Advisors LLC owned approximately 0.17% of Inspire Medical Systems worth $6,484,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of INSP. Quarry LP boosted its stake in shares of Inspire Medical Systems by 2,127.3% during the 1st quarter. Quarry LP now owns 245 shares of the company’s stock worth $39,000 after acquiring an additional 234 shares in the last quarter. Banque Transatlantique SA acquired a new position in Inspire Medical Systems in the 1st quarter worth about $46,000. Smartleaf Asset Management LLC boosted its position in Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company’s stock worth $71,000 after purchasing an additional 97 shares in the last quarter. Farther Finance Advisors LLC boosted its position in Inspire Medical Systems by 14.6% during the second quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock worth $78,000 after purchasing an additional 77 shares in the last quarter. Finally, AlphaQuest LLC grew its holdings in Inspire Medical Systems by 248.5% in the first quarter. AlphaQuest LLC now owns 1,028 shares of the company’s stock valued at $164,000 after purchasing an additional 733 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Price Performance

Shares of Inspire Medical Systems stock opened at $136.75 on Friday. The stock has a market cap of $3.97 billion, a P/E ratio of 93.02, a P/E/G ratio of 16.14 and a beta of 0.70. The stock’s 50 day simple moving average is $90.06 and its 200-day simple moving average is $105.01. Inspire Medical Systems, Inc. has a 1-year low of $70.77 and a 1-year high of $216.01.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.38 EPS for the quarter, beating the consensus estimate of ($0.15) by $0.53. Inspire Medical Systems had a return on equity of 9.41% and a net margin of 5.05%.The firm had revenue of $224.50 million during the quarter, compared to analysts’ expectations of $220.39 million. During the same quarter last year, the firm earned $0.60 earnings per share. The business’s revenue for the quarter was up 10.5% on a year-over-year basis. As a group, research analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems announced that its board has initiated a stock buyback program on Monday, August 11th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the company to purchase up to 8.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity

In other news, Director Shawn Mccormick sold 2,000 shares of Inspire Medical Systems stock in a transaction on Friday, November 28th. The stock was sold at an average price of $127.48, for a total transaction of $254,960.00. Following the transaction, the director owned 26,046 shares in the company, valued at $3,320,344.08. The trade was a 7.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.10% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Zacks Research upgraded Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, October 27th. Evercore ISI decreased their price objective on shares of Inspire Medical Systems from $150.00 to $125.00 and set an “outperform” rating on the stock in a report on Tuesday, October 7th. Leerink Partners cut their target price on shares of Inspire Medical Systems from $116.00 to $97.00 and set a “market perform” rating for the company in a research note on Friday, August 15th. Piper Sandler restated an “overweight” rating and set a $135.00 price target (down previously from $150.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 4th. Finally, JPMorgan Chase & Co. lowered their price objective on Inspire Medical Systems from $110.00 to $82.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Inspire Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $128.13.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.